Doctors
Lia Goliadze

Lia Goliadze

Book Visit
Speciality
Infectious disease specialist, Head of the Infectious Diseases Department
Languages
Georgian, Russian, English
Working Hours
09:30 -17:30
Work Experience

  • Since 2018 — Academician Vakhtang Bochorishvili Clinic, Head of the Adult Infectious Diseases Department;

  • 1987–1989 — Republican Anti-Sepsis Center, Physician of the Therapeutic Department;

  • 1989–1993 — Republican Anti-Sepsis Center, Physician of the Therapeutic Department, Head of the Outpatient Department;

  • 1993–2014 — Republican Anti-Sepsis Center, Head of the Admission and Outpatient Department;

  • 2014–2018 — Academician Vakhtang Bochorishvili Clinic, Head of the Admission and Outpatient Department;

  • Since 2013 — Consultant Infectious Disease Specialist at the National Center of Surgery and “New Life” Clinic;

  • Since 2015 — Consultant Infectious Disease Specialist at Academician O. Gudushauri National Medical Center;

  • 2017–2020 — First University Clinic, Consultant Infectious Disease Specialist;

  • 2019–2024 — Academician Kipshidze Central University Clinic, Consultant Infectious Disease Specialist.
Education

  • 1976–1982 — Tbilisi State Medical University;

  • 1982–1983 — Residency Training;

  • 1984–1987 — Central Clinical Infectious Diseases Hospital.
Awards

  • Member of the Alliance for the Prudent Use of Antibiotics (APUA);

  • Member of the “Sepsis” Association — Georgian Association of Infectious Diseases, Hepatology, Parasitology and Clinical Microbiology;
    Member of the European Association for the Study of the Liver (EASL, 2006, 2008);

  • 2009 — Founder of the Institute of Antimicrobial Chemotherapy “Optima”;

  • Since 2014 — Director of the Institute of Antimicrobial Chemotherapy “Optima”;

Participation in Clinical Trials (Sub-Investigator, SI):

  • CAP (Phase III) — since 2016;

  • Staphylococcus aureus bacteremia including infective endocarditis (Phase III) — 2016–2018;

  • Skin infections (Phase III) — 2014–2015;

  • HAP/VAP (Phase III) — 2013–2015;

  • CAP (Phase II) — 2012;

  • Skin infections (Phase II) — 2011–2012;

  • Chronic Hepatitis C (Phase II);

  • IAI — Intra-abdominal Infections (Phase II) — 2010–2012;

  • HAP — 2005–2007;

  • 2022–2024 — Immunocompromised Adult Patients with Symptomatic COVID-19 Requiring Hospital Care (NEREIDA) — Principal Investigator (PI).